Supplier profile
Bristol Myers Squibb
Every public-sector award we hold for this supplier, across Belgium, Denmark, Spain, France, the UK, Italy, Poland, Portugal and UK, from 3 Jul 2007 to 19 Mar 2026.
Awards won
413
all time
Attributed value
£3.3m + €311.4m + DKK 374.0m
219 shared, unvalued
Buyers
177
public bodies
Active
2007–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Barts Health NHS Trust | 1 | £2.1m |
| Northern Health and Social Care Trust | 3 | £1.2m |
| Amgros I/S | 35 | €3.9m + DKK 374.0m |
| CHRU de Tours | 18 | €131.1m |
| NHS England | 15 | not attributable |
| AP-HM | 12 | €81.0m |
| CHG de Saint-Brieuc | 10 | €526k |
| The NHS Commissioning Board (operating under the name of NHS England) | 10 | not attributable |
| CHU de Nantes | 7 | €6.5m |
| CHU Saint-Étienne | 6 | €1.1m |
What they win
Awards
Showing 1–25 of 413 awards we hold
- France – Pharmaceutical products – FOURNITURE D'OPDUALAG INJECTABLE ↗Centre Hospitalier Universitaire de Nantes€4.0mawarded 19 Mar 2026
- FOURNITURE D'OPDUALAG INJECTABLE ↗CHU de Nantes€4.0mawarded 19 Mar 2026
- Médicaments sous Autorisation d'Accès Compassionnel (AAC) et Autorisation d'Accès Précoce Pré-AMM (AP1) 2026 ↗CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMORshared awardawarded 1 Jan 2026
- anac-it notice ocds-hu01ve-G11727-619a1133-dcd1-4d41-87fe-13e5c19eb93d-01 ↗AZIENDA SANITARIA PROVINCIALE DI MESSINA€91kawarded 15 Dec 2025
- anac-it notice ocds-hu01ve-7LGA_OF_X486 BRISTOL-01 ↗AZIENDA SOCIO SANITARIA TERRITORIALE DEI SETTE LAGHI€40kawarded 2 Dec 2025
- BH_NonClinical_Pharmacy_Car-T ↗Barts Health NHS Trust£2.1mawarded 26 Nov 2025
- France – Medical solutions – Médicaments sous Autorisation d'Accès Compassionnel (AAC) et Autorisation d'Accès Précoce Pré-AMM (AP1) 2026 ↗CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMORshared awardawarded 13 Nov 2025
- Spain – Various medicinal products – Suministro de los principios activos denominados "Mavacamten 15 MG ORAL", "Mavacamten 5 MG ORAL", "Mavacamten 10 MG ORAL","Deucravacitinib 6MG" Y "Fedratinib 100 MG". ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€174kawarded 2 May 2025
- Suministro de los principios activos denominados "Mavacamten 15 MG ORAL", "Mavacamten 5 MG ORAL", "Mavacamten 10 MG ORAL","Deucravacitinib 6MG" Y "Fedratinib 100 MG". ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€174kawarded 1 May 2025
- Denmark – Pharmaceutical products – Amgros 2025 1.475.a ↗Amgros I/Sshared awardawarded 22 Nov 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.162.a ↗Amgros I/Sshared awardawarded 19 Nov 2024
- Denmark – Pharmaceutical products – Amgros 2025 2.3.b ↗Amgros I/Sshared awardawarded 18 Oct 2024
- Contract for POMALIDOMIDE (Imnovid) Capsules ↗Northern Health and Social Care Trust£280kawarded 1 Oct 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1470.a ↗Amgros I/Sshared awardawarded 3 Sept 2024
- Denmark – Pharmaceutical products – Amgros 2024 1.1157.a ↗Amgros I/Sshared awardawarded 28 Aug 2024
- Denmark – Pharmaceutical products – Amgros 2025 1.1171.a ↗Amgros I/Sshared awardawarded 11 Jul 2024
- France – Antineoplastic and immunomodulating agents – AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) ↗CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMORshared awardawarded 28 May 2024
- Denmark – Pharmaceutical products – Amgros 2024 1.967.b ↗Amgros I/Sshared awardawarded 27 Apr 2024
- Contract for POMALIDOMIDE (Imnovid) Capsules ↗Northern Health and Social Care Trust£400kawarded 30 Jan 2024
- France-Saint-Brieuc: Pharmaceutical products ↗centre hospitalier saint brieucshared awardawarded 22 Dec 2023
- Ao Médicaments Sous Autorisation d'Accès Compassionnel (Aac) et Autorisation d'Accès Précoce Pré-Amm (Ap1) 2024 ↗CENTRE HOSPITALIER SAINT BRIEUCshared awardawarded 21 Dec 2023
- Fourniture de spécialités pharmaceutiques au profit des adhérents du GCS GRAPS Grand Est ↗GCS GRAPS GRAND ESTshared awardawarded 27 Nov 2023
- France – Pharmaceutical products – Fourniture de spécialités pharmaceutiques au profit des adhérents du GCS GRAPS Grand Est ↗GCS GRAPS GRAND ESTshared awardawarded 14 Nov 2023
- Denmark-Copenhagen: Pharmaceutical products ↗Amgros I/Sshared awardawarded 7 Nov 2023
- Denmark-Copenhagen: Pharmaceutical products ↗Amgros I/S£374.0mawarded 7 Nov 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Bristol-Myers Squibb; S.A.306 awards
- BRISTOL-MYERS SQUIBB S.R.L.124 awards
- Bristol-Myers Squibb AB11 awards
- Bristol Myers Squibb, S. L.4 awards
- BRISTOL-MYERS SQUIBB, S.L.U.2 awards
- Bristol MYERS Squibb SpA2 awards
- Bristol-Myers Squibb (Finland) AB1 award
- Bristol Myers Squibb NV1 award
- Bristol-Myers Squibb Oy Ab1 award
- bristol myers squibb sarl1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.